Cargando…

Long-Term Follow-Up of Patients after Percutaneous Coronary Intervention with Everolimus-Eluting Bioresorbable Vascular Scaffold

BACKGROUND: Bioresorbable vascular scaffolds (BVS) were developed to improve the long-term results of percutaneous coronary intervention, restoring vasomotion. OBJECTIVES: To report very late follow-up of everolimus-eluting Absorb BVS (Abbott Vascular, Santa Clara, USA) in our center. METHODS: Obser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meneguz-Moreno, Rafael Alexandre, Costa Junior, José de Ribamar, Moscoso, Freddy Antônio Britto, Staico, Rodolfo, Tanajura, Luiz Fernando Leite, Centemero, Marinella Patrizia, Chaves, Auréa Jacob, Abizaid, Andrea Claudia Leão de Sousa, Sousa, Amanda Guerra de Moraes Rego e, Abizaid, Alexandre Antonio Cunha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344654/ https://www.ncbi.nlm.nih.gov/pubmed/28076449 http://dx.doi.org/10.5935/abc.20160202

Ejemplares similares

Miniaturized Self-Expanding Drug-Eluting Stent in Small Coronary Arteries: Late Effectiveness
por: de Oliveira, Flavio Roberto Azevedo, et al.
Publicado: (2013)

Correlation between Plaque Composition as assessed by Virtual Histology and C-reactive Protein
por: Siqueira, Dimytri Alexandre de Alvim, et al.
Publicado: (2013)

Adequação das Práticas do Laboratório de Cateterismo durante a Pandemia de COVID-19: O Protocolo do Instituto Dante Pazzanese de Cardiologia
por: Chamié, Daniel, et al.
Publicado: (2020)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

Comparison of neointimal coverage between ultrathin biodegradable polymer‐coated sirolimus‐eluting stents and durable polymer‐coated everolimus‐eluting stents: 6 months optical coherence tomography follow‐up from the TAXCO study
por: Abhyankar, Atul, et al.
Publicado: (2020)

Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
por: Dalos, Daniel, et al.
Publicado: (2016)

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial
por: Arroyo, Diego, et al.
Publicado: (2014)

Renal Denervation Using an Irrigated Catheter in Patients with Resistant Hypertension: A Promising Strategy?
por: Armaganijan, Luciana, et al.
Publicado: (2014)

Progression and Prognosis of Paravalvular Regurgitation After Transcatheter Aortic Valve Implantation
por: Meneguz-Moreno, Rafael Alexandre, et al.
Publicado: (2017)

Chronic total occlusion successfully treated with a bioresorbable everolimus-eluting vascular scaffold
por: Rama-Merchan, Juan Carlos, et al.
Publicado: (2014)

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
por: Desperak, Piotr, et al.
Publicado: (2020)

Five‐year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular scaffolds
por: Schukraft, Sara, et al.
Publicado: (2021)

A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent With Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial
por: Abizaid, Alexandre, et al.
Publicado: (2023)

Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience
por: Remkes, W. S., et al.
Publicado: (2017)

Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions
por: Fam, Jiang Ming, et al.
Publicado: (2017)

One-year efficacy and safety of everolimus-eluting bioresorbable scaffolds in the setting of acute myocardial infarction
por: Kim, Yongcheol, et al.
Publicado: (2020)

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice
por: Lee, Joo Myung, et al.
Publicado: (2023)

Coronary Artery Vessel Healing Pattern, Short and Long Term, After Implantation of the Everolimus‐Eluting Bioresorbable Vascular Scaffold
por: Kraak, Robin P., et al.
Publicado: (2015)

Initial Experience of Two National Centers in Transcatheter Aortic Prosthesis Implantation
por: Lluberas, Sebastián, et al.
Publicado: (2014)

Long-term follow-up of therapeutic efficacy of everolimus-eluting bioresorbable vascular scaffold in comparison to everolimus-eluting stent in treatment of chronic total occlusion guided by intracoronary imaging
por: Eltahlawi, Mohammad Abdallah, et al.
Publicado: (2020)

Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea
por: Kwon, Osung, et al.
Publicado: (2018)

Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold
por: Madanchi, Mehdi, et al.
Publicado: (2021)

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
por: Cakal, Beytullah, et al.
Publicado: (2020)

One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
por: Pivato, Carlo A., et al.
Publicado: (2022)

Comparative assessment of “plaque/media” change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study
por: Zeng, Yaping, et al.
Publicado: (2016)

Safety and efficacy of biolimus-eluting stent with biodegradable polymer: insights from EINSTEIN (Evaluation of Next-generation drug-eluting STEnt IN patients with coronary artery disease) Registry
por: de Souza, Cristiano Freitas, et al.
Publicado: (2013)

Transcatheter aortic valve replacement in elderly patients
por: Siqueira, Dimytri, et al.
Publicado: (2012)

Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
por: Brugaletta, Salvatore, et al.
Publicado: (2011)

Recent Least Burdensome Approach for the Approval of Innovative Medical Devices in Japan -Regulatory Approval Review of an Everolimus-eluting Bioresorbable Scaffold-
por: Konishi, Akihide, et al.
Publicado: (2020)

Correction to: One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
Publicado: (2022)

Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study
por: Simonsen, Jo Krogsgaard, et al.
Publicado: (2019)

Primary Mitral Valve Regurgitation Outcome in Patients With Severe Aortic Stenosis 1 Year After Transcatheter Aortic Valve Implantation: Echocardiographic Evaluation
por: Florentino, Thiago Marinho, et al.
Publicado: (2017)

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial
por: Sabaté, Manel, et al.
Publicado: (2016)

Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study
por: Hommels, T. M., et al.
Publicado: (2019)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent
por: Toelg, Ralph, et al.
Publicado: (2020)

Comparison of a Bioresorbable, Magnesium-Based Sirolimus-Eluting Stent with a Permanent, Everolimus-Eluting Metallic Stent for Treating Patients with Acute Coronary Syndrome: the PRAGUE-22 Study
por: Toušek, Petr, et al.
Publicado: (2021)

Invasive Physiological Assessment: From Binary to Continuous
por: Chamié, Daniel, et al.
Publicado: (2020)

Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry
por: Gori, Tommaso, et al.
Publicado: (2019)

In-stent restenosis due to delayed healing of abluminal bioresorbable polymer everolimus-eluting stent: insight from histopathological evaluation with directional coronary atherectomy
por: Yamamoto, Hiroyuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fbunh46o1rkbqlamsl868t734p